WOW WOW WEDNESDAY

TODAY’S TRADING STRATEGY

OF NIFTY FUTURES – NOV 3

Day support @ 6130

& actually above this no problem for BULLS

If breaches 6130 Nifty Futures comes down to

6114-03 and thereafter upto 6096.

If a turn is not made around 6096,

Non-stop fall upto 6072-48 is seen.

On the other hand,

Decisively after crossing 6172

it would kiss 6197 and there after a rally upto

6221-38 is possible if good volume is generated today

BANK NIFTY

Buy btwn 12883-908

T1 – 12950-71

T2 – 12984-92-13018

Sell btwn 12797-71

T1 – 12729-08

T2 – 12695-87-61

SHARE TIPS TODAY (NOV 3)

Sell JSWSteel @ 1327

T- 1318

Sell Everonn @ 640.25

T1 – 635.25

T2 – 630.25

Sell Sobha @ 358

T1 – 355.5

T2 – 352.5

Sell TataMTRDVR @ 825

T - 818

AN ASTRAL VIEW FOR NOV 3

• Consider 10 minutes plus and minus in each prediction and act accordingly.
• Ganesha advises you to compare the next prediction with the prediction of the previous time slot.
• Be cautious on 1st November, 2010; after that, the entire month of November is likely to yield benefits.
• The pre-opening period at the market may seem negative, but avoid the 'up & down' position as the current situation may be confusing.
• From opening to 12:10, there may be three small corrections at Nifty; overall, the period is glitch-free.
• From 12:10 to 13:35, market breadth may be positive, notes Ganesha.
• From 13:35 till the end of the day, Ganesha feels that there is a possibility of small correction at Nifty.

Disclaimer

On repeated requests of the readers this astral prediction is started.

Traders are advised to attain some technical knowledge before they get into trades anyway

-EDITOR

A FRENCH DOCTOR ACCUSED

The Securities and Exchange
Commission accused a French
medical doctor with illegally tipping
off a hedge-fund manager about

the results of a clinical trial conducted
by Human Genome Sciences

Inc.,
prompting the manager to dump
roughly six million shares

of the drug maker.
The SEC alleged in the civil complaint Tuesday

that Dr. Yves M. Benhamou gave the hedge-fund manager nonpublic

information about negative developments in the trial of the drug

Albuferon, used to treat Hepatitis C, including that one trial

participant had died…Over a period of weeks prior to the

announcement, the hedge-fund manager ordered the sale of all

Human Genome Sciences stock held by six hedge funds he

co-managed, a stake of roughly six million shares, the SEC said.

(Please refer to ‘OUR POLICIES’ before you leave the site)

For further details,

Contact
MAHIDEESH
-Admin (Analyst) @

(0)9788563656

MESSAGE TODAY

They can do all because they think they can.

-VIRGIL, Aeneid

RELAX CORNER

JUST SMS TO YOUR PAL

Mobile phones are the only things in live of which men talk about having the smallest.